Welcome to our dedicated page for Health In Tech SEC filings (Ticker: HIT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Health In Tech, Inc. filings document material-event disclosures for a Nevada operating company with Class A common stock listed on the Nasdaq Capital Market under HIT. Recent Form 8-K reports cover results of operations and financial condition, Regulation FD materials, investor presentations and conference-call transcripts.
The filing record also addresses capital-structure matters, including a private investment in public equity financing, and governance disclosures involving executive officer departures, compensatory arrangements and related consulting agreements. The company identifies as an emerging growth company in its Exchange Act reports.
Health In Tech, Inc. filed an initial ownership report for Chief Technology Officer Rajagopalan Sridharan, showing beneficial ownership of 20,000 shares of Class A common stock. These are restricted shares granted under the Health in Tech Equity Incentive Plan and vest in equal monthly installments over twelve months, starting on February 23, 2026, subject to his continued service with the company.
Health In Tech, Inc. reported that Chief Growth Officer Hasan Zain Syed received 200,000 restricted shares of Class A common stock on January 6, 2026 under the Health in Tech Equity Incentive Plan. These shares are tied to two proposed issuer transactions. Half of the grant vests in equal monthly installments over 12 months starting at the closing of the first transaction, and the other half vests monthly over 12 months starting at the closing of the second transaction, in each case subject to continued service. If either transaction does not close within 24 months after January 6, 2026, the unvested shares relating to that transaction will be automatically forfeited without payment. Following this grant, Syed beneficially owns 220,000 restricted shares of Class A common stock, held directly.
Health In Tech, Inc. reported that Chief Executive Officer, director and 10% owner Tim Johnson received a grant of 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 at a price of $0 per share under the Health In Tech Equity Incentive Plan. The grant is tied to two proposed issuer transactions: half of the shares vest in equal monthly installments over 12 months starting at the closing of the first transaction, and the other half vest monthly over 12 months starting at the closing of the second transaction, in each case subject to continued service.
If either transaction does not close within 24 months after January 6, 2026, any unvested shares relating to that transaction will be automatically forfeited without consideration. Following this award, Johnson beneficially owns 23,549,741 shares of Class A Common Stock, including 1,126,130 restricted shares and 22,423,611 unrestricted shares.
Health In Tech, Inc. officer and director LinLin Qian reported an award of 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 under the Health in Tech Equity Incentive Plan at a price of $0 per share. The grant is tied to two proposed issuer transactions, with half of the shares vesting in equal monthly installments over 12 months after the closing of the first transaction and the other half vesting monthly over 12 months after the closing of the second transaction, subject to continued service.
If either transaction does not close within 24 months after January 6, 2026, any unvested shares related to that transaction will be forfeited without consideration. Following this grant, Qian beneficially owns 9,128,555 Class A shares, including 1,119,130 restricted shares and 8,009,425 unrestricted shares, and also holds but does not count here 2,700,000 Class B shares and 711,510 options to purchase Class A shares.
Health In Tech, Inc. reported that its Chief Technology Officer, Imran Yousuf, was terminated from his position on November 25, 2025. The company states that the termination was without cause and was not the result of any disagreement regarding its operations, policies, or practices. This update focuses solely on the leadership change and does not describe any changes to the company’s strategy or business activities.
Health In Tech, Inc. reported Q3 2025 results, showing strong growth and continued profitability. Revenue reached $8,490,093, up from $4,458,921 a year ago, while gross profit rose to $5,143,816 from $3,479,293. Operating expenses increased to $4,650,293 from $3,040,411 as the company invested in growth and platform capabilities. Net income was $452,176, compared with $376,086 in Q3 2024.
For the nine months, revenue was $25,818,926 versus $14,586,342, with net income of $1,581,399 versus $814,629, reflecting expanded SMR program fees and higher ICE underwriting revenue. Cash and cash equivalents were $8,023,613, supported by $2,682,602 provided by operating activities and offset by $2,358,213 invested in software development. The company recorded contra revenue tied to a carrier portfolio adjustment of $1,413,345 in Q3 and $2,369,088 year-to-date, with an $869,088 refund liability recorded. As of November 10, 2025, shares outstanding were 45,208,808 Class A and 11,700,000 Class B.
Health In Tech, Inc. furnished an earnings call transcript under Item 7.01. The call, held on November 10, 2025, covered financial and operating results for the quarter ended September 30, 2025. The transcript is included as Exhibit 99.1.
The information is deemed “furnished,” not “filed,” under the Exchange Act. A replay is available via the Company’s Investor Relations site through approximately February 8, 2026.
Health In Tech, Inc. (HIT) furnished an update on its quarterly results. The company reported that it issued a press release announcing results for the quarter ended September 30, 2025, and made that release available as Exhibit 99.1.
The disclosure was furnished under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). The information in these items, including Exhibit 99.1, is expressly stated as “furnished” and not “filed” under the Exchange Act. The filing also includes customary forward‑looking statements language referring to risks described in the company’s periodic reports.
Health In Tech, Inc. (HIT) furnished an investor presentation under Regulation FD, making it available as Exhibit 99.1 to an 8-K. The materials are expressly deemed “furnished” and not “filed” under the Exchange Act, which means they are not subject to Section 18 liability and are not incorporated by reference into other filings. The company also included customary forward-looking statements language outlining risks referenced in prior SEC reports.
Health In Tech, Inc. (HIT) reported an insider equity award. On 11/05/2025, the company’s CISO, Michael Clarkson, received 8,000 restricted shares of Class A Common Stock coded “A” at a price of $0.00 under the Health in Tech Equity Incentive Plan. Following the grant, he beneficially owns 8,000 shares, held directly.
The restricted shares vest in equal monthly installments over twelve months, commencing on November 1, 2025, contingent on continued service through each vesting date. This filing reflects routine equity compensation for an officer rather than an open‑market transaction.